Biotechnology Value Fund L P

13F Holdings History for Cidara Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CDTX)

Symbol: CDTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 1.19M shares
Security Ownership: 4.4%

BVF PARTNERS L P/IL ownership in Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX)

2025-10-17 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.19M shares of Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX). This represents 4.4% percent ownership of the company. In their previous filing dated 2025-10-17, BIOTECHNOLOGY VALUE FUND L P had reported owning 1.41M shares, indicating a decrease of -15.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BVF PARTNERS L P/IL	4.4%	-16%	$114M	1.19M	-225,000	-15.9%	$95.76	13G/A	10/15/2025	17 Oct 2025 16:48:08
BVF PARTNERS L P/IL	5.2%	-47.9%	$135M	1.41M	+161,724	+12.9%	$95.76	13G/A	9/30/2025	17 Oct 2025 16:45:23
BVF PARTNERS L P/IL	9.99%		$21.4M	1.25M	+158,942	+14.5%	$17.10	13G/A	3/31/2025	15 May 2025 16:25:28
BVF PARTNERS L P/IL	9.99%		$18.7M	1.09M			$17.10	13G/A	12/31/2024	14 Feb 2025 16:05:19